Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms EXTEND-IA TNK
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 26 Jan 2018 Primary endpoint (Proportion of patients with substantial angiographic reperfusion (mTICI) score of 2b/3 (restoration of blood flow to 50% of the affected arterial territory) or absence of retrievable thrombus at initial angiogram: non-inferiority and superiority of tenecteplase compared to alteplase) has been met, according to results presented at the International Stroke Conference 2018.
- 26 Jan 2018 Results presented at the International Stroke Conference 2018.